1-5 of 5
Paolo Corradini, MD, PhD
Close
Sort by
Journal Articles

Pomalidomide + Low-Dose Dexamethasone in Patients with Refractory or Relapsed and Refractory Multiple Myeloma and Renal Impairment: Analysis of Patients from the Phase 3b Stratus Trial (MM-010)

Katja Weisel, MD, Meletios A. Dimopoulos, MD, Michele Cavo, MD, Enrique M. Ocio, MD PhD, Antonio Palumbo, MD, Paolo Corradini, MD PhD, Michel Delforge, MD PhF, Albert Oriol, MD, Harmut Goldschmidt, MD, Concetta Conticello, MD, Angelo Vacca, MD PhD, Markus Hansson, MD PhD, Neil Miller, CRS, Teresa Peluso, MBBS, Lars Sternas, MD, Mohamed H. Zaki, MD, Philippe Moreau, MD
Journal: Blood
Blood (2014) 124 (21): 4755.
https://doi.org/10.1182/blood.V124.21.4755.4755
Published: 2014
Journal Articles

Outcomes for Older Patients in Stratus (MM-010), a Single-Arm, and Phase 3b Study of Pomalidomide + Low-Dose Dexamethasone in Refractory or Relapsed and Refractory Multiple Myeloma

Antonio Palumbo, MD, Meletios A. Dimopoulos, MD, Katja Weisel, MD, Michele Cavo, MD, Enrique M. Ocio, MD PhD, Paolo Corradini, MD PhD, Michel Delforge, MD PhF, Albert Oriol, MD, Hartmut Goldschmidt, MD, Maria Jesus Blanchard, MD, Concetta Conticello, MD, Angelo Vacca, MD PhD, Markus Hansson, MD PhD, Ana Slaughter, PhD, Mathew Simcock, MSc, Jennifer Herring, MD, Teresa Peluso, MBBS, Lars Sternas, MD, Mohamed H. Zaki, MD PhD, Philippe Moreau
Journal: Blood
Blood (2014) 124 (21): 4770.
https://doi.org/10.1182/blood.V124.21.4770.4770
Published: 2014
Journal Articles

Safety and Efficacy in the Stratus (MM-010) Trial, a Single-Arm Phase 3b Study Evaluating Pomalidomide + Low-Dose Dexamethasone in Patients with Refractory or Relapsed and Refractory Multiple Myeloma

Meletios A. Dimopoulos, MD, Antonio Palumbo, MD, Katja Weisel, MD, Enrique M. Ocio, MD PhD, Michele Cavo, MD, Paolo Corradini, MD PhD, Michel Delforge, MD PhF, Albert Oriol, MD, Hartmut Goldschmidt, MD, María Jesús Blanchard, MD, Chantal Doyen, MD, Gareth J Morgan, MD PhD, Mathew Simcock, MSc, Neil Miller, CRS, Ana Slaughter, PhD, Teresa Peluso, MBBS, Lars Sternas, MD, Mohamed H. Zaki, MD PhD, Philippe Moreau, MD
Journal: Blood
Blood (2014) 124 (21): 80.
https://doi.org/10.1182/blood.V124.21.80.80
Published: 2014
Journal Articles

Direct Healthcare Costs of Treated Multiple Myeloma: Results from a Population-Based Study

Alessandro Corso, Enrica Morra, MD, Paolo Corradini, MD PhD, Monica Galli, MD, Anna Maria Cafro, MD, Roberta Ciampichini, Paolo Cozzolino, Virginio Chiodini, Claudia Crippa, MD, Giuseppe Rossi, Giancarlo Cesana, Lorenzo Giovanni Mantovani
Journal: Blood
Blood (2014) 124 (21): 1315.
https://doi.org/10.1182/blood.V124.21.1315.1315
Published: 2014
Journal Articles

Autologous Stem Cell Transplantation Followed by Reduced Intensity Allogeneic Stem Cell Transplantation (Tandem Transplantation) as Treatment for Advanced Resistant Hodgkin’s Lymphoma Patients. A Retrospective Analysis of the Lymphoma Working Party (LWP) of the European Group for Blood and Marrow Transplantation (EBMT).

Ivan Alvarez, MD, Carme Canals, MD, Goli Taghipour, Angelo M. Carella, MD, PhD, Yves Beguin, MD, PhD, Didier Blaise, MD, PhD, Danielle Lazzlo, MD, PhD, Bernardino Aillone, MD, PhD, Jean H. Bourhis, MD, PhD, Lucca Castagna, MD, PhD, Paolo Corradini, MD, PhD, Paolo Iacopino, MD, PhD, Giuseppe Milone, MD, PhD, Pedro Pimentel, MD, PhD, Nigel H. Russell, MD, PhD, Pierre Zachee, MD, PhD, Anna Sureda, MD, PhD
Journal: Blood
Blood (2006) 108 (11): 3044.
https://doi.org/10.1182/blood.V108.11.3044.3044
Published: 2006